Cassava Sciences' Simufilam Trial Faces Fresh FDA Scrutiny
The FDA's Mifepristone Review: A Political Maneuver Masquerading as Science?
EchoStar Breathes Easy: FCC Drops 5G Obligation Review After Landmark SpaceX Spectrum Deal
Treasury Secretary Demands Sweeping Federal Reserve Review, Questions Regulatory Authority